該当箇所へ

USA Open Forum

Hosted by EMD Serono
Billerica, MA, USA | October 4, 2022

Join the Genedata Biopharma Open Forum hosted by EMD Serono to learn why the world's most innovative R&D-driven organizations are using Genedata Biologics® and Genedata Bioprocess®, the industry-leading E2E workflow platforms for increasing efficiency and throughput in biotherapeutic discovery and development.

Pfizer, Novartis, EMD Serono, and Merck KGaA, Darmstadt, Germany will present case studies showcasing how they use the platforms to streamline R&D workflows and transform operations. Genedata product experts will provide an update on the latest product developments and an outlook on upcoming new functionalities.

Join the Open Forum to find out how others have deployed, implemented, and adopted Genedata Platforms to make their biopharma R&D faster and better.

Space is limited for this free event and is on a first-come, first-served basis.

Agenda

Tuesday, October 4, 2022
 
9:30–10:00 amRegistration & Welcome Coffee
10:00–10:15 amWelcome & Opening Remarks
Klaus Urbahns, Ph.D., Site Head, EMD Serono, Billerica, MA, USA 
10:15–11:00 am Genedata Biopharma Platform Introduction
Streamlining & Increasing Efficiency of Large-Molecule R&D Workflows
Jo Terragni, Ph.D., Head of US Operations, Biologics, Genedata, Lexington, MA, USA 
11:00–11:30 amEMD Serono Keynote Presentation
Predicting Successful Biologics: The Quest for Relevant Preclinical Models Continues
Vanita Sood, Ph.D., Global Head of Drug Disposition & Design Discovery & Development Technologies, EMD Serono, Billerica, MA, USA
11:30–12:00 pmNovartis Case Study
Synergies Within and Beyond the Genedata Biopharma Platform
Barbara Brannetti, Ph.D., Director, Data Science, Novartis Institutes for BioMedical Research (NIBR), Cambridge, MA, USA
12:00–1:00 pmLunch
1:00–1:30 pmPfizer Case Study
Digitalization of QC Analysis for Gene Therapy
Diana Sapashnik, Scientist, BioMedicine Design, Pfizer, Cambridge, MA, USA
1:30–2:10 pmEMD Serono Case Studies
Automating to Increase Efficiency and Accuracy – Impact of Software
Vera Sellers, Ph.D., Senior Scientist, EMD Serono, Billerica, MA, USA

Automating Aggregation and Analysis of Complex Molecule Assay Data
Uwe Wittenberg, Ph.D., Director, Research & Lab Informatics, Merck KGaA, Darmstadt, Germany
2:10–2:30 pmRefreshment Break
2:30–3:00 pmLive Demonstrations
Key Genedata Workflows
Yi-Wei Lee, Ph.D., Scientific Consultant, Biologics, Genedata, Lexington, MA, USA
Christian Tooley, Ph.D., Scientific Consultant, Biologics, Genedata, Lexington, MA, USA
3:00–3:45 pmPanel Discussion
Moderated by Jana Hersch, Ph.D., Head of Corporate Scientific Engagement, Genedata, Lexington, MA, USA
Panelists
Joel Bard, Ph.D., Associate Research Fellow, BioMedicine Design, Pfizer, Cambridge, MA, USA
Barbara Brannetti, Ph.D., Director, Data Science, Novartis Institutes for BioMedical Research (NIBR), Cambridge, MA, USA
Vanita Sood, Ph.D., Global Head of Drug Disposition & Design Discovery & Development Technologies, EMD Serono, Billerica, MA, USA

 
3:45–4:00 pmClosing Remarks
Jana Hersch, Ph.D., Head of Corporate Scientific Engagement, Genedata, Lexington, MA, USA
4:00 pmEnd of Open Forum

 

Location & Directions

EMD Serono Research and Development Institute, Inc.
45A Middlesex Turnpike
Billerica, MA 01821, USA
Horizon Building
Visitor parking is available next to the building. Please use the main entrance. You will be greeted in the lobby and taken through security.

Directions

Registration

Online registration for the Genedata Biologics Open Forum at EMD Serono is open. If you have questions, please send an email to openforum@genedata.com.

Frequently Asked Questions

The Genedata Open Forum is held free of charge. We only ask that all attendees register in advance to ensure that we have enough space and food for lunch and breaks.

This event will be held in person so participants can fully take advantage of the opportunity to exchange ideas during the breaks, lunch, and panel discussions. However, we are happy to share speaker presentations after the event if you are unable to attend in person.

The health and safety of participants is a top priority. Our events follow local public health guidelines at the time of the event. We will provide hand sanitizers and masks, which will be optional except where required by law.